Brief: Caribou Biosciences Reports Fourth Quarter Loss Per Share Of $0.31

Caribou Biosciences

21/03/2022 20:06

March 21 (Reuters) - Caribou Biosciences Inc  CRBU.O :
    * CARIBOU BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * CARIBOU BIOSCIENCES INC - HAD $413.5 MILLION IN CASH, CASH
EQUIVALENTS, AND MARKETABLE SECURITIES AS OF DECEMBER 31, 2021
    * CARIBOU BIOSCIENCES INC QTRLY LOSS PER SHARE $0.31
    * CARIBOU - CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES AS
OF
DEC 31, 2021 SUPPORT ADVANCEMENT OF ALLOGENEIC CAR-T AND CAR-NK
CELL THERAPIES

Source text for Eikon:  ID:nGNX7HflNn 
Further company coverage:  CRBU.O 

 ((Reuters.Briefs@thomsonreuters.com;))